Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - ACCOUNTS PAYABLE
Accounts Payable REGN - Regeneron Pharmaceuticals, Inc.
607 M
LAST VALUE
3.71%
2 YEAR CAGR
22.69%
5 YEAR CAGR
25.63%
10 YEAR CAGR